CEO and Cofounder, Signal
Hemant Taneja, a managing director at the $7 billion venture-capital firm General Catalyst, is a nontraditional investor.
He doesn’t think “move fast and break things” works anymore in Silicon Valley. Perhaps best known for investments like Snap and Stripe, Taneja also has a long track record of backing healthcare innovators.
He says he wants to shrink the size of the healthcare market, contrary to other investors, by making services cheaper
Taneja takes an active role in his portfolio. He invested in and confounded Livongo, as one example, a startup focused on treating people with diabetes.
The 10-year-old company went public last year. Since then, it has surpassed a $10 billion market value. In August, telehealth giant Teladoc struck an $18.5 billion deal for Livongo.
“It's really the first consumer-focused digital health company that went public and has done well,” Taneja tells Business Insider.
Livongo’s inspired companies to focus on other patients and conditions with digital tech, like Plume for transgender care and Sprout Therapy for kids who have autism, he says.
“And that has accelerated due to covid,” he adds.